BioNTech SE Revenue From Contracts With Customers
BioNTech SE (BNTX) reported Revenue From Contracts With Customers of EUR 2.87 billion for the 12-month period ending 2025-12-31, per its 20-F filed 2026-03-10.
Financial Statements › Income Statement › Other Income
ifrs-full:RevenueFromContractsWithCustomers · last filed 2026-03-10
| Period end | Revenue From Contracts With Customers 12 month | Revenue From Contracts With Customers 12 month as first filed |
|---|---|---|
| 2025-12-31 | 2.87B EUR 20-F · filed 2026-03-10 | |
| 2024-12-31 | 2.75B EUR 20-F · filed 2026-03-10 | |
| 2023-12-31 | 3.82B EUR 20-F · filed 2026-03-10 | |
| 2022-12-31 | 17.31B EUR 20-F · filed 2025-03-10 | |
| 2021-12-31 | 18.98B EUR 20-F · filed 2024-03-20 | |
| 2020-12-31 | 482.30M EUR 20-F · filed 2023-03-27 | 482.32M EUR 20-F · filed 2021-03-30 |
| 2019-12-31 | 108.60M EUR 20-F/A · filed 2022-10-26 | 108.59M EUR 20-F · filed 2020-03-31 |
| 2018-12-31 | 127.58M EUR 20-F · filed 2021-03-30 | |
| 2017-12-31 | 61.60M EUR 20-F · filed 2020-03-31 |